Private company
BELLICUM PHARMACEUTICALS, INC
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
-1798.7%Operating margin3
-1664.9%Net margin3
-75.8%Revenue growth, 20223
-1239.4%Return on equity3
-$25.8MFree cash flow3
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Research and development100¢$22.8M
- Income tax0¢$2.0K
Out of $1.5M in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | $388.0K4 | $185.0K5 | $1.1M6 | $7.1M7 | $500.0K7 | $6.2M3 | $1.5M3 |
| Cost of revenue | $864.0K5 | $436.0K5 | |||||
| Research and development | $51.3M4 | $65.7M5 | $71.6M6 | $64.5M7 | $39.1M8 | $23.6M3 | $22.8M3 |
| Operating income | -$68.4M4 | -$87.4M5 | -$95.5M6 | -$87.4M7 | -$51.7M8 | -$24.9M3 | -$27.0M3 |
| Interest | $1.8M4 | $3.7M5 | $4.2M6 | $4.3M7 | $2.7M8 | $4.0K8 | |
| Income tax | $03 | $2.0K3 | |||||
| Net income | -$69.2M4 | -$91.8M5 | -$98.0M6 | -$112.5M7 | -$7.7M8 | -$9.7M3 | -$25.0M3 |
| Earnings per share | -$1.348 | -$0.843 | -$0.813 | ||||
| Earnings per share (diluted) | -$1.348 | -$0.843 | -$0.813 |
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Cash | $33.1M4 | $38.8M5 | $43.7M6 | $91.0M7 | $35.5M8 | $46.2M3 | $21.8M3 |
| Current assets | $105.6M4 | $101.7M5 | $95.3M6 | $111.9M7 | $39.4M8 | $49.1M3 | $23.8M3 |
| Total assets | $132.0M4 | $135.5M5 | $121.5M6 | $116.2M7 | $40.6M8 | $49.1M3 | $23.8M3 |
| Current liabilities | $15.1M4 | $12.2M5 | $15.8M6 | $94.4M7 | $24.7M8 | $6.7M3 | $3.8M3 |
| Long-term debt | $18.4M4 | $34.9M5 | $35.8M6 | $25.7M7 | $07 | ||
| Total liabilities | $35.5M4 | $50.9M5 | $53.0M6 | $121.0M7 | $25.0M8 | $6.7M3 | $3.8M3 |
| Shareholders’ equity | $96.6M5 | $84.6M6 | $68.5M7 | -$26.2M8 | -$2.5M3 | $24.4M3 | $2.0M3 |
| Shares outstanding | 27.2M shares4 | 33.3M shares5 | 4.4M shares6 | 5.0M shares7 | 8.3M shares8 | 8.4M shares3 | 8.6M shares3 |
Former names
- BELLICUM PHARMACEUTICALS INCMar 23, 2006 to Jul 29, 20082
Recent filings
- Feb 23, 20248-K
- Feb 21, 20248-K
- Jan 30, 20248-K
- Jan 24, 20248-K
- Dec 14, 20238-K
- Nov 24, 20234 FORM 4 SUBMISSION
- Nov 22, 20238-K
- Nov 14, 202310-Q
- Sep 29, 20238-K
- Aug 21, 20238-K
- Aug 10, 202310-Q
- Jun 2, 20238-K
- May 30, 20238-K
- May 11, 202310-Q
- May 5, 20233 FORM 3 SUBMISSION
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11